The mammalian retromer complex consists of SNX1, SNX2, Vps26, Vps29 and Vps35, and retrieves lysosomal enzyme receptors from endosomes to the trans-Golgi network. The structure of human Vps26A at 2.1-Å resolution reveals two curved b-sandwich domains connected by a polar core and a flexible linker. Vps26 has an unpredicted structural relationship to arrestins. The Vps35-binding site on Vps26 maps to a mobile loop spanning residues 235-246, near the tip of the C-terminal domain. The loop is phylogenetically conserved and provides a mechanism for Vps26 integration into the complex that leaves the rest of the structure free for engagements with membranes and for conformational changes. Hydrophobic residues and a glycine in this loop are required for integration into the retromer complex and endosomal localization of human Vps26, and for the function of yeast Vps26 in carboxypeptidase Y sorting.
The biosynthetic sorting of acid hydrolase precursors from the transGolgi network (TGN) to the endosomal-lysosomal system is central to the biogenesis of lysosomes in metazoans. In mammals, this sorting is directed by binding of mannose 6-phosphate groups on the hydrolases to two transmembrane receptors known as the cation-dependent and cation-independent mannose 6-phosphate receptors (CD-MPR and CI-MPR, respectively) 1 . At the TGN, the hydrolase-receptor complexes are packaged into carrier vesicles by several coat and adaptor proteins, including clathrin, adaptor protein-1 (AP-1) and Golgi-localized gamma ear-containing ADP ribosylation factor-binding (GGA) proteins 1, 2 . These carrier vesicles bud from the TGN and fuse with endosomes. Within the endosome, the acidic pH in the lumen triggers the release of the hydrolases from their receptors. The hydrolases are carried with the fluid phase to lysosomes, whereas the receptors return to the TGN to be reused in further rounds of sorting. Several proteins and complexes, including AP-1 (refs. 3,4) , tail-interacting protein of 47 kDa (TIP47) 5 and phosphofurin acidic cluster sorting protein (PACS-1) 6 , have been implicated in the transport of MPRs from endosomes to the TGN.
A similar process has been described in yeast cells for the sorting of acid hydrolases to the vacuole, which is the fungal equivalent of the mammalian lysosome. Carboxypeptidase Y (CPY) is sorted by the Vps10 transmembrane receptor. Genetic screens in yeast have identified more than 60 vacuolar protein sorting (Vps) gene products 7 , which are involved in the transport of CPY to the vacuole. Five yeast Vps proteins, Vps5, Vps17, Vps26, Vps29 and Vps35, form a complex named the retromer that is required for Vps10 sorting from endosomes to the late Golgi 8 . Vps5 and Vps17 belong to the sorting nexin family and form a distinct subcomplex [9] [10] [11] . Vps5 and Vps17 contain Phox homology (PX) and Bin/amphiphysin/Rvs (BAR) domains. PX domains target proteins to endosomal membranes by binding the lipid phosphatidylinositol 3-phosphate [12] [13] [14] [15] [16] , and BAR domains are banana-shaped modules that target to curved vesicular or tubular membranes through their concave face 17 . Vps35 and Vps29 form a stable cargo-recognition subcomplex, with Vps35 directly binding the Vps10 cytosolic tail 18 .
A homologous retromer complex consisting of five subunits termed SNX1, SNX2, Vps26, Vps29 and Vps35 has been described in humans 8 . Depletion of some of these subunits in vivo by RNAmediated interference (RNAi) impairs retrieval of the CI-MPR and results in its mis-sorting to lysosomes, where the receptor is degraded [19] [20] [21] . The membrane targeting of mammalian retromer seems to be mediated, at least in part, by the sorting nexins, SNX1 and SNX2 (refs. 20,22) . Vps35 directly interacts with the CI-MPR cytoplasmic tail, suggesting that it constitutes a cargo-recognition subunit of the complex 19 . Recently, the structures of mouse and human Vps29 were determined, revealing that Vps29 has an inactive form of a divalent metal-containing phosphoesterase fold 23, 24 . Vps29 uses two different exposed hydrophobic patches to bind Vps35 and sorting nexins, respectively 24 .
The function of the Vps26 subunit has been the least clear of any of the five subunits. There are no homologous proteins of known structure or function and few clues as to its role within the complex. Vps26 is required for embryonic development in mice 25 and is downregulated in Alzheimer disease 26 , highlighting its importance in mammalian physiology. Two isoforms of Vps26, Vps26A and Vps26B, are encoded by the mouse genome, and both can interact with other retromer subunits 27 . To further understand the assembly of the retromer and the function of Vps26 in retrograde trafficking, we solved the structure of human Vps26A (herein referred to as Vps26) at 2.1-Å by X-ray crystallography. The structure reveals that Vps26 is a close structural relative of the arrestins, an extensively characterized family of proteins involved in receptor internalization at the plasma membrane 28 . Vps26 shares not only the same overall fold as the arrestins, but an unusual polar core as well. Using a combination of structure-based mutagenesis and yeast two-hybrid assays, we show that Vps26 interacts directly with Vps35 through a loop near the distal tip of the C-terminal domain. This interaction is essential for the assembly of Vps26 into the retromer complex and its recruitment to endosomes in mammalian cells, and for function of the retromer complex in vacuolar sorting of CPY in yeast. The combination of structural homology, the known properties of the arrestins and the mapping of the Vps35-binding site onto the structure allows us to advance a working model for the function of this subunit.
RESULTS

Structure determination of Vps26
The full-length 327-residue human Vps26 protein crystallizes in space group P2 1 2 1 2 1 . The crystal structure was determined using MAD from both selenomethionine (SeMet)-substituted protein crystals and platinumsoaked derivative crystals, together with isomorphous replacement using native and platinum-derivative crystals ( Supplementary  Fig. 1 online) . Vps26 behaves as a monomer in solution during purification and packs as one molecule per asymmetric unit in the crystal. Within the crystal, tubes that run the length of the crystal are formed where concavities in each Vps26 monomer are juxtaposed to each other ( Supplementary Fig. 2 online). The refined model contains residues 6-299 with a gap between 239 and 244 owing to missing electron density. Residue 161 on the linker between two domains also shows poor density. The final model was refined to 2.1 Å with R free ¼ 28% and R-factor ¼ 23%.
Molecular architecture of Vps26
The Vps26 molecule consists of two domains; each of them folds into a deeply curved b-sandwich (Fig. 1a) . Each sandwich is formed by a four-stranded antiparallel b-sheet packed against an antiparallel b-sheet of three or four strands in the N-terminal domain (N domain) or C-terminal domain (C domain), respectively. The N domain contains residues 6-148 and the C domain includes residues 164-299. There is a 15-residue loop, from 149 to 163 (L10), that connects the two domains. This loop is relatively mobile, with poor electron density for several residues centered on Asn161. The N domain and the C domain are related by an intramolecular pseudo two-fold rotation axis, and their superposition using 59 Ca atoms from core b-strands yields an r.m.s. deviation of 1.5 Å . The surface of the inner b-sheet of each domain is polar. Residues at the outer layer of the b-sandwich from the C domain have high B-factors (above 70 Å 2 on average), with residues 239-244 missing from the electron density map, indicating that this region is more mobile than the rest of the protein. Vps26 is electrically polarized. Its surface contains a prominent basic patch and two acidic patches (Fig. 2a) . The residues in the basic patch are conserved from yeast to human (Fig. 1b) . The second acidic patch straddles the interface between two domains and is only partially conserved in yeast. An electropositive patch at the far end of the N domain consists of well-conserved residues Lys61, Arg62, Arg138 and Arg139 (Fig. 2a,c) . Furthermore, several phenylalanine residues protrude into solution immediately adjoining the basic patch (Fig. 2c) . This combination of exposed hydrophobic and basic residues is a hallmark of membrane-binding structures 29 , and it suggested to us that Vps26 could interact with membranes via this motif. However, we used surface plasmon resonance to test binding to a range of liposomes containing phosphatidylinositol 3-phosphate and other acidic lipids, and we did not observe any noticeable interaction, as compared to a series of well-characterized control proteins (data not shown). The Vps26 N domain could bind to membranes too weakly to localize to membranes on its own; however, it could be a secondary interaction site in the context of the larger complex assembled on the membrane.
The interface between the N domain and the C domain buries 1,964 Å 2 of solventaccessible surface area (Fig. 3) , including 700 Å 2 of polar surface and 1,264 Å 2 of nonpolar surface. The hydrophobic interaction is formed by residues from the body of the N domain, the body of the C domain and the linker loop. Twelve hydrophobic residues participate in this interaction. An extensive buried polar core is formed between the two domains ( Fig. 3a,b) . The polar core includes N domain residues Glu119 and Tyr121 and C domain residues Lys213, Glu215, Thr258, Tyr272 and Arg296 (Figs. 1 and 3) . The most extensive buried hydrogen bond network occurs between the Tyr121, Lys213 and Glu215 side chains and the main chain amino groups from Ala124 and Asn125 (Fig. 3c) . The second network is formed by a buried salt bridge between Glu119 and Arg296 (Fig. 3d) . With the exception of Lys213, residues involved in forming these interactions are highly conserved in Vps26 proteins, suggesting that they are crucial in protein function (Fig. 1b) .
Structural homology to the arrestins
The fold of Vps26 closely resembles that of the arrestin family members, despite the absence of detectable sequence similarity (Fig. 4) , as shown by a search of the Protein Data Bank 30 . Superimposing Vps26 with visual arrestin (v-arrestin) 31 using Cas of corresponding b-strands results in r.m.s. deviations of 1.4 Å between N domains (63 Ca atoms) and 1.5 Å between C domains (94 Ca atoms). One of the defining features of arrestin family proteins is the existence of a polar core embedded between the two domains. Vps26 shares this feature in the general sense that the domain interface contains clusters of buried polar interactions (Fig. 4a,b) . The overall extents of the polar cores are similar, although the identities of individual amino acids are not conserved (Fig. 4c,d ).
Mapping the binding site for Vps35 on Vps26
Vps26 interacts directly with Vps35 (refs. 32, 33) . To identify the binding site for Vps35 on Vps26, we constructed 30 mutants of Vps26 carrying substitutions of surface residues ( Table 1 and Fig. 5 , constructs 1-30). These mutations included nonconservative substitutions of single residues or clusters of 2-4 residues, and in one case the replacement of the loop comprising residues 238-246 by a Gly-Gly linker sequence. The design of this latter mutation enabled deletion of the loop while still allowing the linkage of the adjoining sequences without conformational distortion of the protein. The choice of these mutation sites was based on several criteria: conservation, exposed hydrophobic residues, location in concave surface regions, correspondence to functional sites in arrestin and unusually strong positive or negative electrostatic potential, all of which are likely properties of interaction sites. The interaction of these Vps26 mutants with Vps35 was tested using a yeast two-hybrid system in which Vps26 variants and Vps35 were expressed as fusions with the transcription activation domain (Gal4AD) and DNA-binding domain (Gal4BD) of the Gal4 transcription factor, respectively. We observed that the mutation I235D M236D (construct 16) or deletion of the 238-246 loop (construct 18; D238-246 GG) abrogated interaction with Vps35, whereas the other 28 mutations had no detectable effect (Fig. 5a ). Figure 5 . ++, normal growth; +, reduced growth in the presence of 10 mM 3-AT; ±, lack of growth in the presence of 10 mM 3-AT; -, no growth. c Coprecipitation of Vps35 and Vps29 with wild-type or mutant Vps26-myc expressed by transfection in HeLa cells was performed as in Figure 6 . +, normal assembly; -, reduced or no assembly. d Colocalization (+) or lack thereof (-) of wild-type or mutant Vps26-myc with SNX1 on endosomes in HeLa cells, analyzed as in Figure 6 . For each condition, 50-75 cells from three independent experiments were examined. e CPY processing and secretion were analyzed as in Figure 7 . For both assays, + denotes normal function and -denotes reduced function.
Immunoblot analysis showed that the binding-defective mutants were expressed at levels similar to those of wild-type Vps26 and other Vps26 mutants (Fig. 5b) . Notably, both of these mutations map to the same region of Vps26, the distal tip of the C domain (Fig. 5d) . The 28 other single and multiple mutations tested represent coverage of a total of 69 surface residues, including all of the likely interaction sites. The lack of any effect on the Vps35 interaction rules out these regions as candidate binding sites. We conclude that Vps35 binds a single isolated site on Vps26 located at one tip of the molecule.
To map the determinants of Vps26 binding to Vps35 in more detail, several additional mutations in the loop region were generated ( Table 1 and Fig. 5c, constructs 31-34) . The histidine biosynthesis inhibitor 3-aminotriazole (3-AT) was used in one set of assays to achieve higher stringency and resolve weaker mutational effects. The entire mobile loop was replaced by a polyserine linker in one construct, 238-246 polyS. This mutant construct showed interaction with Vps35 in the absence of 3-AT, but not in its presence (Fig. 5c) . Similarly, substitution of loop residue Gly238 by proline resulted in detection of an interaction with Vps35 in the absence, but not the presence, of 3-AT (Fig. 5c) . A construct consisting of only loop residues 232-247 did not interact with Vps35 in the two-hybrid assay (data not shown). We conclude that the mobile loop and adjacent residues are the primary binding site for Vps35. The loop is not autonomous, however, and it must be presented in the context of the Vps26 fold.
To determine whether the same mutations affected the assembly of Vps26 with Vps35 in human cells, we transfected HeLa cells with mammalian expression plasmids encoding myc-tagged wild-type or mutant Vps26 constructs (Fig. 6) . These constructs were then isolated by immunoprecipitation with an antibody to the myc epitope and the immunoprecipitates were analyzed by SDS-PAGE and immunoblotting with antibodies to Vps35 and Vps29. We found that, whereas the wild-type and R69A E71A Vps26 constructs coprecipitated endogenous Vps35 and Vps29, the I235D M236D, D238-246 GG, 238-246 polyS and G238P Vps26 constructs did not (Fig. 6a) . This was despite similar levels of expression of all recombinant myc-tagged constructs in the transfected cells (Fig. 6a) . Therefore, mutations in the loop and adjacent regions not only prevent interaction of Vps26 with Vps35 but also block the incorporation of Vps26 into the endogenous Vps26-Vps29-Vps35 subcomplex. This is consistent with the notion that Vps26 interacts with retromer only in the context of the Vps26-Vps29-Vps35 subcomplex and defines the mechanism of Vps26 integration into the retromer.
We also examined the intracellular localization of the different myctagged Vps26 constructs by immunofluorescence microscopy. We observed that, whereas the wild-type and R69A E71A Vps26 constructs colocalized with endogenous SNX1 on endosomes, the I235D M236D, D238-246 GG, 238-246 polyS and G238P Vps26 constructs showed a diffuse cytosolic distribution (Fig. 6b) . These results agree with those of the coprecipitation experiments and provide further evidence that recruitment of Vps26 to endosomes requires its assembly with Vps29 and Vps35.
Next, we investigated the effect of Vps26 mutations on retromer function in Saccharomyces cerevisiae. Yeast Vps26 was tagged at its C terminus with green fluorescent protein (GFP), and mutants were constructed that were analogous to those previously made using human Vps26. The resulting Vps26-GFP constructs were expressed by transformation into a Vps26-null yeast strain (vps26D). The transformed strains were then examined for expression of the different Vps26 constructs and for processing and secretion of Table 1 ) fused to Gal4AD was analyzed using the yeast two-hybrid system. Ability to grow in the absence of histidine (-His) is indicative of interactions. A summary of the results from three independent experiments is presented in Table 1 
, were subjected to SDS-PAGE and immunoblotting (IB) using polyclonal antibodies to Vps35 (top) and Vps26 (bottom). (c) Additional Vps26 mutants were tested for interaction with Vps26 using the yeast two-hybrid system. A summary of the results is presented in Table 1 CPY. Immunoblot analysis showed that all the Vps26 constructs were expressed at similar levels (Fig. 7a) . In vps26D cells transformed with wild-type Vps26-GFP, most of the Golgi precursor (p2) form of CPY was processed to the mature (M) form, as determined by metaboliclabeling, pulse-chase analysis (Fig. 7b, lane 1) . In contrast, vps26D strains transformed with GFP-tagged I318D M319D, D321-328 GG, 321-328 polyS or G321P, or with GFP alone, showed a marked CPY processing defect, as indicated by the accumulation of the p2 form of CPY (Fig. 7b, lanes 2-6) . A colony-blotting assay similarly showed that vps26D cells expressing I318D M319D, D321-328 GG, 321-328 polyS or G321P Vps26 constructs tagged with GFP, or expressing GFP alone, secreted higher amounts of CPY than that secreted by vps26D cells expressing wild-type Vps26-GFP (Fig. 7c) . From these experiments, we conclude that the ability of Vps26 to be incorporated into the retromer complex is essential for retromer function. Finally, we mutated residues in the polar core of Vps26 (including the following mutations, in the format of human position/yeast position: Y121F/Y150F, N125R/N155D, E215R/E298R and E215R/ E298R; Table 1 ) and investigated the effect on recruitment of Vps26 to endosomes in human cells and rescue of CPY secretion in vps26D yeast cells. We found that these mutants behaved like wild-type Vps26 in both assays ( Table 1 and data not shown). These results are consistent with incorporation of Vps26 into the retromer complex being mediated by the distal tip of the C-terminal domain of Vps26, not its polar core. Additionally, these findings indicate that single mutations in the polar core of yeast Vps26 do not abrogate its function in CPY sorting.
DISCUSSION
The first major observation in this study is the unpredicted structural similarity between the retromer subunit Vps26 and the arrestin family of trafficking proteins. Vps26 and the arrestins have in common an unusual polar core that links the two b-sandwich domains. The arrestins have emerged as an important class of trafficking adaptor proteins 28, 34 . Arrestins directly bind clathrin, the adaptor protein complex AP-2, the ubiquitin ligase Mdm2, the small GTPase ARF6, the nucleotide exchange factor ARNO, the plasma membrane phospholipid phosphatidylinositol (4,5)-diphosphate (PIP 2 ) and a range of receptors and other signaling proteins 28 . The clathrin-binding, phosphoprotein, ubiquitination and PIP 2 -binding sites found in the arrestins are absent in Vps26, however. Although the receptor-binding cups in the N and C domains of arrestin correspond to cups of a very similar shape and polarity in Vps26, the detailed nature of the residues is not conserved. Two yeast dominant-negative mutants of unknown biochemical effect 33 map to the N domain cup, which corresponds to part of the G-protein-coupled receptor (GPCR)-binding site in the arrestins. These two residues are similar in human and other Vps26 orthologs, suggesting that at least the N domain cup has an important function in Vps26.
The inactive conformations of v-arrestin 31 C-terminal loop and the polar core. The active conformation of arrestin has been inferred from mutational 38 and proteolytic 39 analyses. Upon receptor phosphorylation, a phospho-serine in the receptor tail binds Arg175 in the polar core. This destabilizes the polar core such that the two b-sandwich domains can reorient with respect to each other and embrace the GPCR through their concave surfaces 40 . v-arrestin Arg175 is replaced by hydrophobic residues in Vps26 orthologs, suggesting that there is no arrestin-like phosphate sensor in the Vps26 family. We have mutated four polar-core residues in Vps26, and these mutations do not interfere with endosomal localization in human cells or CPY sorting in yeast, so the functional significance of the polar core in Vps26 is currently unclear.
The second major observation in this study is that Vps26 binds Vps35 and is integrated into the retromer complex via an exposed surface loop near the tip of the C-terminal domain. As the Vps35-binding site involves only the tip of one domain, Vps35 interactions should be independent of any rearrangements of the two Vps26 domains relative to each other. This would allow Vps26 to undergo a regulatory conformational cycle while remaining integrated in the complex. The importance of this loop is highlighted by its conservation in Vps26 orthologs and paralogs. A second Vps26 isoform, Vps26B, has recently been described 27 and is reported to localize to the plasma membrane, rather than to endosomes. As the surface loop contains the determinants for the endosomal localization of Vps26A, it will be interesting to understand the mechanism for the apparently distinct localization of Vps26B. This loop is also conserved in yeast Vps26. We have found a marked correlation between loss of human Vps35 binding and endosomal localization in tissue-culture cells and loss of the CPY-sorting function in yeast.
The determinants for Vps35 binding include two hydrophobic residues and a glycine residue. The key role of a glycine suggests that the loop binds a well-defined pocket on the surface of Vps35 that requires an unusual conformation of the loop, is sterically tightly packed or both. One precedent for such a role for a glycine residue is provided by the GGA appendage-binding motifs of rabaptin-5 and related proteins 41, 42 . The key functional role of the two hydrophobic residues suggests a hydrophobic character for at least part of the pocket on Vps35.
Vps26 has been the most mysterious of the five retromer subunits because of the absence of recognizable homology to any other protein of known structure or function and the lack of identified interactions with other proteins. The findings in this study now provide a structural foothold for understanding the function of Vps26 orthologs. We now know that Vps26 shares a common architecture with the arrestins. The similarities are extensive enough to suggest that Vps26 undergoes an arrestin-like conformational change that enables it to bind transmembrane receptors of some kind. It will be important to test this idea and to seek the identity of the putative receptors that interact with Vps26 orthologs and the factors that control the putative conformational change. Although these concepts of receptor binding and conformational change remain to be tested, the observations in this study provide compelling evidence for a mechanism by which Vps26 orthologs are assembled into the retromer. We have found that the Vps35-binding site on Vps26 is essential for localization in mammalian cells and for function in yeast, and it seems likely that these findings will be general across other species.
METHODS
Protein expression, purification and crystallization. PCR was used to amplify the complementary DNA coding for human Vps26A and to add a C-terminal His 5 tag (GLVPRGSHHHHH). The product was inserted into the pmr101A (modified pmr101; American Type Culture Collection) vector using the NdeI and XhoI restriction sites. The expressed recombinant protein contains the additional dipeptide Met-Gly at the N terminus as a result of the vector construction. Protein was expressed in the BL21 (DE3) star (Invitrogen) strain at 20 1C overnight. Vps26 was purified on a 5-ml HiTrap chelating HP column (GE Healthcare) and eluted with a gradient of 12.5-300 mM imidazole in a buffer containing 20 mM Tris (pH 8.0), 50 mM NaCl and 5% (v/v) glycerol. The eluted fractions were pooled, diluted by adding an equal volume of water and purified by ion exchange (5-ml HiTrap Q FF) and gel filtration (Superdex 75 16/60) (GE Healthcare). Fractions were pooled and concentrated to 8 mg ml -1 in 10 mM Tris (pH 8.0), 5% (v/v) glycerol, 100 mM NaCl and 10 mM DTT for crystallization.
Diffraction-quality crystals used for native data collection were obtained using buffer containing 100 mM sodium cacodylate (pH 6.5), 15% (v/v) glycerol, 8% (w/v) PEG 10,000, 10 mM DTT and 1 mM TmCl 3 by microseeding. SeMet-substituted protein was produced using the same strain growing in media containing 1 g NH 4 Cl, 3 g KH 2 PO 4 , 6 g Na 2 HPO 4 7H 2 O, 2.5 g NaAcÁ3H 2 O, 1.5 g succinic acid, 20 g glucose, 500 mg MgSO 4 7H 2 O, 13.9 mg FeSO 4 Á7H 2 O and 10 ml Kao and Michayluk vitamin solution (100Â) (Sigma) per liter, and the pH was adjusted to 7.4 with NaOH. D,LSeMet was added to the media when the cells had grown to A 600 ¼ 0.5, to a final concentration of 100 mg ml -1 . The culture was induced 20 min after the addition of SeMet and harvested after overnight incubation at 20 1C. The expression, purification and crystallization of the selenium-derivative protein were carried out under the same conditions as that of native protein, except that GdCl 3 was used as a crystallization additive instead of TmCl 3 . A platinum derivative was prepared by soaking native crystals in buffer containing 100 mM sodium cacodylate (pH 6.5), 20% (v/v) glycerol, 8% (w/v) PEG 10,000 and 10 mM Pt(NH 3 ) 2 Cl 2 at 23 1C for 5 d.
Data collection and structure determination. Data were collected at 98 K at beamline ID-22, Advanced Photon Source (APS, Argonne National Lab; Table 2 ) and processed with HKL2000 (HKL Research). The structure was determined by combining a two-wavelength MAD data set from a SeMet crystal, a three-wavelength MAD data set from a platinum crystal and a single isomorphous replacement (SIR) analysis using the platinum crystal as a derivative. Six ordered selenium sites and one platinum site were identified using SOLVE 43 . Subsequent phasing and solvent flattening was carried out using SOLVE 43 and RESOLVE 44 . The solved structure revealed electron density attached to the two cysteine residues of Vps26; we attribute this to covalently bound dimethylarsenate, which was included in the refined model. Iterative cycles of model building and refinement were carried out using the O 45 , CNS 46 and CCP4 47 program packages. A portion (8.8%) of the data was used for cross-validation in CNS.
Recombinant DNA constructs. An EcoRI-XhoI fragment encoding human Vps26A (residues 2-327) obtained from the Vps26A-pB42AD construct 32 was subcloned into the corresponding sites of the pGADT7 vector (Clontech) and the pcDNA3.1/myc-His vector (Invitrogen). Addition of a start codon (position 1) and removal of a stop codon (position 327) from the Vps26A-pcDNA3.1 construct was done by site-directed mutagenesis. An MfeI-BamHI fragment encoding Vps35 (residues 2-796) was obtained from the Vps35-pLexA construct 32 and later subcloned into the EcoRI and BamHI sites of the pGBKT7 vector (Clontech). An EcoRI-BamHI fragment encoding full-length S. cerevisiae Vps26p was cloned into the pRS316 (C-terminal GFP) vector. Mutagenesis of the Vps26A-pGADT7, Vps26A-myc-pcDNA3.1 and Vps26p-pRS316 constructs was performed using the QuikChange site-directed mutagenesis kit (Stratagene). All the constructs were sequenced to confirm their identities and the presence of the desired mutations.
Yeast two-hybrid assay. The S. cerevisiae strain AH-109 (Clontech) was transformed by the lithium acetate procedure. Yeast cells were cotransformed with cDNAs encoding wild-type Vps35 fused to Gal4BD (Vps35-pGBKT7) and wild-type or mutant Vps26A fused to GAL4AD (Vps26-pGADT7). After selection, the cotransformants were spotted on plates containing or lacking histidine. As negative controls, the AH-109 strain was cotransformed with Vps26-pGADT7 and pGBKT7, Vps35-pGBKT7 and pGADT7, and the 'empty' vectors pGBKT7 and pGADT7. As a positive control for growth on histidinelacking plates, cells were cotransformed with p53-pGBKT7 and SV40-LT-AgpGADT7 (Tag). AH-109 transformants were grown overnight at 30 1C in media lacking leucine and tryptophan. The day of the experiment, the yeast cell cultures were diluted to A 600 ¼ 0.4 and grown for 2 h at 30 1C. The cells were then harvested at 1,000g, washed and resuspended in medium lacking leucine and tryptophan to 0.1 A 600 ml -1 . Five ml of each suspension was spotted on plates lacking leucine and tryptophan, in the presence or absence of histidine, and incubated at 30 1C for 2-3 d. Whole-cell lysates of the transformants were obtained according to published protocols 48 and subjected to SDS-PAGE and immunoblot analysis.
Immunoprecipitation. HeLa cells (American Type Culture Collection) were cultured on 100-mm dishes as described previously 49 . When the cells reached 80%-90% confluency, they were transfected with 24 mg of pcDNA3.1 encoding myc-tagged forms of wild-type, I235D M236D, D238-246 GG, 238-246 polyS, G238P or R69A E71A Vps26, using Lipofectamine 2000 (Invitrogen). At 24 h after transfection, cells were washed twice with ice-cold PBS and immediately resuspended in 1 ml lysis buffer (0.5% (v/v) Triton X-100, 300 mM NaCl, 50 mM Tris-HCl (pH 7.4), 5 mM EDTA) supplemented with a protease inhibitor cocktail (Roche). After 30 min of incubation at 4 1C, lysates were centrifuged at 16,000g for 15 min. The supernatants were then precleared by incubation for 60 min at 4 1C with 30 ml protein G-Sepharose beads (Amersham Pharmacia Biotech) and centrifugation at 8,000g for 5 min. The precleared lysates were incubated for 2 h at 4 1C with 30 ml protein G-Sepharose beads bound to mouse monoclonal antibody to myc (9E10; Covance). After immunoprecipitation, the beads were washed four times with ice-cold wash buffer (0.1% (w/v) Triton X-100, 300 mM NaCl, 50 mM Tris-HCl (pH 7.4)) and once with ice-cold PBS. Washed beads were then subjected to SDS-PAGE and immunoblotting analysis. Antibodies to Vps29 and Vps35 have been described 32 .
Immunofluorescent labeling and scanning-laser confocal microscopy. HeLa cells grown on glass cover slips and transfected with wild-type and mutant Vps26A-myc-pcDNA3.1 constructs were washed with PBS and fixed for 10 min with 4% (w/v) paraformaldehyde in PBS at room temperature. Cells were rinsed twice with PBS, and excess paraformaldehyde was quenched with PBS containing 20 mM glycine (pH 8.0) and 75 mM NH 4 Cl for 15 min at room temperature. The cells were again washed with PBS and permeabilized with 0.025% (w/v) saponin prepared in blocking solution (PBS containing 5% (v/v) goat serum and 7 mg ml -1 fish skin gelatin) for 10 min at 37 1C in a humidified chamber. Cells were immunostained with mouse monoclonal antibody to myc (9E10) and polyclonal antibody to SNX1 for 2 h at 37 1C, then incubated with fluorescently labeled secondary antibodies. Imaging was performed on a TCS SP-2 confocal microscope (Leica) equipped with argon-krypton and 543/594-nm helium-neon lasers. Images were acquired using a Â63 PlanApochromat oil objective (NA 1.4) and the appropriate filter combination. Settings were as follows: photomultipliers set to 500-700 V, Airy ¼ 1, zoom ¼ 3.0-4.0, Kalman filter (n ¼ 8). The images (512 Â 512 pixels) were saved in a tag information file format (TIFF), contrast was corrected in Adobe Photoshop and images were imported into Macromedia Freehand MX.
Yeast growth and CPY-sorting assays. The Vps26D::KanMX deletion S. cerevisiae strain was obtained from Research Genetics (Invitrogen), and its ability to sort and process CPY was compared with the parental strain BY4742 (data not shown). Yeast cells were maintained on YPD plates or grown in liquid medium before transformation with yeast expression plasmids. Transformation with pRS316 encoding GFP-tagged forms of wild-type, I318D M319D, D321-328 GG, 321-328 polyS or G321P Vps26, or encoding GFP, into the vps26D strain was performed by the lithium acetate procedure.
Cells transformed with wild-type and mutant Vps26p-GFP-pRS316 were metabolically labeled with the 35 S Express reagent (Perkin Elmer Life Sciences) for 10 min (pulse) and chased for 30 min as previously described 48 . Three crystals were used for structure solving and refinement. Highest-resolution shell is shown in parentheses.
Immunoprecipitations using mouse anti-CPY (Molecular Probes) conjugated to protein G-Sepharose beads were performed overnight at 4 1C as previously described 48 and the immunoprecipitates were analyzed by SDS-PAGE and autoradiography. Dried gels were also scanned on a PhosphorImager (Typhoon 9200, Molecular Dynamics). The CPY colony blot assay was adapted from ref. 50 . Yeast transformants grown in selection medium (A 600 ¼ 10 À3 ) were spotted onto a YPD plate and overlaid with a nitrocellulose membrane. The plates were incubated for 22-24 h at 30 1C. The nitrocellulose membranes were washed with water and immunoblotted with mouse anti-CPY and the appropriate horseradish peroxidaseconjugated secondary antibody. Visualization was done with enhanced chemiluminescence reagents (Perkin Elmer Life Sciences).
Accession codes. Protein Data Bank: Coordinates have been deposited with accession code 2FAU.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
